Yuanyuan Zhang

Yuanyuan Zhang obtained her PhD degree in Bioinformatics from Peking University, where she focused on tumor immune microenvironment and cancer immunotherapy in Prof. Zemin Zhang’s lab. She joined the Bernstein lab in 2022, and has interests in deciphering the epigenetic regulations of tumor development and drug resistance using single cell technologies.

Sonia Cohen, MD, PhD

Sonia is a surgeon-scientist interested in understanding gene regulation in cancer.

Alba Meira, PhD

Alba joined the lab in 2021 as a Sir Henry Wellcome Fellow. Originally from Spain, she undertook her PhD at the University of Oxford before moving to Boston. She is interested in deciphering in the epigenetic mechanisms that lead to tumor development and evolution using single cell technologies.

Zeyu Chen, PhD

Interests: Epigenetic circuits in immune cells; High dimensional profiling in tumor microenvironments Zeyu Chen did his undergraduate at Peking University in Beijing, China, studying stem cell genetic engineering in Dr. Hongkui Deng’s lab. He then worked as a research assistant in Dr. Richard Flavell’s lab at Yale for one year, and did his Ph.D. at University … Continued

Elena Torlai Triglia, PhD

Computational and molecular biologist, interested in multidisciplinary approaches to understand gene regulation in healthy cells and during cancer development. Orcid: 0000-0002-6059-0116  https://www.linkedin.com/in/elena-torlai-triglia/ https://elenatt.github.io/cv/

Eli Cytrynbaum

Interests: Cell fate decisions and epigenetic buffering; tissue specific DNA architecture based vulnerabilities to cancer Eli joined the lab in 2020 and is currently studying the role of mitochondrial MDM2 in liposarcoma, both from a wet lab and computational perspective.

Gabriel Griffin, MD

Gabriel Griffin earned his undergraduate and medical degrees at Duke University and completed his residency and fellowship training in hematopathology at the Brigham and Women’s Hospital. In his post-doctoral research, Gabe is studying the epigenetic regulation of immune sensitivity in cancer. Gabe is a recipient of the Physician-Scientist Training Award from the Damon Runyon Cancer Research Foundation.